Cevdet Samikoglu, Biosplice CEO
February 8, 2022 09:47 AM EST
People

Bios­plice, a for­mer an­ti-ag­ing uni­corn, slash­es staff in lat­est episode of its long fall from grace

Kyle Blankenship

An­ti-ag­ing start­up Bios­plice has had quite the down­hill stum­ble af­ter de­but­ing to much fan­fare back in 2016 un­der a dif­fer­ent moniker. Now, the biotech is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times